drug · small molecule
patient view →elacestrant hydrochloride
Marketedupdated 2mo agoby A. Menarini Industrie Farmaceutiche Riunite Srl🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for male breast carcinoma and breast neoplasm and 1 investigational indication.
targets
Estrogen receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that